New Blood Pressure Study Recruiting Participants
|New Blood Pressure Study Recruiting Participants
We are conducting a research study to explore the impact of infertility on physicians and physician trainees employed in Memphis, TN. As a part of your participation in this study, you will be asked to complete an online survey, and an individual Zoom interview. Participants will be given a $25 Amazon gift card after completing the interview.
Part of the Department of Physical Therapy’s mission is to meet the physical therapy needs of society by advancing the profession through education, research, service, and patient care. This is made apparent through many areas of the program, including its public service within Clínica Esperanza, also known as the Clinic of Hope. Clínica Esperanza, with the support… Read More
For Immediate ReleaseJune 28, 2023 Tennessee businesses and families know the impact global supply chain shortages have on everyday life. When COVID-19 hit and global supply chains were disrupted, computer chips were in short supply, and the entire country felt the effect of U.S. dependence on foreign manufacturing. In response, Congress passed the bipartisan CHIPS and… Read More
A University of Tennessee Health Science Center (UTHSC) research team is poised to make a real-world impact on vulnerable cancer patients, thanks to new support from the State of Tennessee. Led by David Schwartz, MD, chair of the Department of Radiation Oncology in the College of Medicine, and founding director of the UTHSC Center for Health… Read More
Dear Colleagues and Friends, We are pleased to announce that we are bringing a finalist to campus for the position of executive vice chancellor and chief operations officer at the UT Health Science Center. This position is the Chancellor’s leading senior administrative officer for day-to-day internal and external campus operations and is an integral member… Read More
Sign up today for a free 1-on-1 session with a biostatistician or epidemiologist.
The Molecular Resource Center (MRC) is continuing discounted pricing on Illumina platform next-generation sequencing for projects submitted by the end of FY24.